ArticlePostepy dermatologii i alergologii2021

Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature.

Nawaf AlMutairi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.